{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T15:10:41Z","timestamp":1713453041055},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T00:00:00Z","timestamp":1444780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s11695-015-1920-3","type":"journal-article","created":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T14:15:42Z","timestamp":1444832142000},"page":"1163-1166","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["How Effective Is the Quadruple Concomitant Helicobacter Pylori Eradication Therapy for Obese Patients Undergoing Gastric Bypass Surgery?"],"prefix":"10.1007","volume":"26","author":[{"given":"Rute M.","family":"Cerqueira","sequence":"first","affiliation":[]},{"given":"Manuel R.","family":"Correia","sequence":"additional","affiliation":[]},{"given":"H\u00e9lder","family":"Vilar","sequence":"additional","affiliation":[]},{"given":"M. Concei\u00e7\u00e3o","family":"Manso","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,10,14]]},"reference":[{"key":"1920_CR1","first-page":"1565","volume":"48","author":"M Quina","year":"2001","unstructured":"Quina M, Guerreiro A. Gastric cancer (carcinoma) and Helicobacter pylori: situation in Portugal. Hepato Gastroenterol. 2001;48:1565\u20138.","journal-title":"Hepato Gastroenterol"},{"key":"1920_CR2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/annonc\/mdl498","volume":"18","author":"J Ferlay","year":"2007","unstructured":"Ferlay J, Autier P, Boniol M, et al. Estimates of cancer incidence and mortality in Europe in 2006. Ann Oncology. 2007;18:581\u201392.","journal-title":"Ann Oncology"},{"issue":"9","key":"1920_CR3","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s11695-010-0254-4","volume":"21","author":"RM Cerqueira","year":"2011","unstructured":"Cerqueira RM, Manso MC, Correia MR, et al. Helicobacter pylori eradication therapy in obese patients undergoing gastric by-pass surgery \u2013 fourteen days superior to seven days? Obes Surg. 2011;21(9):1377\u201381.","journal-title":"Obes Surg"},{"key":"1920_CR4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.soard.2007.06.008","volume":"3","author":"BJ Watkins","year":"2007","unstructured":"Watkins BJ, Blackmun S, Kuehner ME. Gastric adenocarcinoma after Roux-en-Y gastric bypass: access and evaluation of excluded stomach. Surg Obes Relat Dis. 2007;3:644\u20137.","journal-title":"Surg Obes Relat Dis"},{"key":"1920_CR5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1381\/096089202321144568","volume":"12","author":"G Silechia","year":"2002","unstructured":"Silechia G, Catalano C, Gentileschi P, et al. Virtual gastroduodenoscopy: a new look at the bypassed stomach and duodenum after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg. 2002;12:339\u201348.","journal-title":"Obes Surg"},{"key":"1920_CR6","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3748\/wjg.14.1946","volume":"14","author":"KR Gill","year":"2008","unstructured":"Gill KR, McKinney JM, Stark ME, et al. Investigation of the excluded stomach after Roux-en-Y gastric bypass: the role of percutaneous endoscopy. World J Gastroenterol. 2008;14:1946\u20138.","journal-title":"World J Gastroenterol"},{"key":"1920_CR7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1067\/mge.2001.112181","volume":"53","author":"H Yamamoto","year":"2001","unstructured":"Yamamoto H, Sekine Y, Sato Y, et al. Total enteroscopy with a nonsurgical steerable double-balloon method. Gastrointest Endosc. 2001;53:216\u201320.","journal-title":"Gastrointest Endosc"},{"key":"1920_CR8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.ijo.0803560","volume":"31","author":"M Fried","year":"2007","unstructured":"Fried M, Hainer V, Basdevant A, et al. Inter-disciplinary European Guidelines on surgery of severe obesity. Int J Obes. 2007;31:569\u201377.","journal-title":"Int J Obes"},{"key":"1920_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gie.2008.01.028","volume":"68","author":"ASGE Guidelines","year":"2008","unstructured":"ASGE Guidelines. Role of endoscopy in the bariatric patient. Gastrointest Endosc. 2008;68:1\u201310.","journal-title":"Gastrointest Endosc"},{"key":"1920_CR10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/SLE.0000000000000050","volume":"24","author":"G Orlando","year":"2014","unstructured":"Orlando G, Pilone V, Vittiello A, et al. Gastric cancer following bariatric surgery. Surg Laparosc Endosc Percutan Tech. 2014;24:400\u20135.","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"key":"1920_CR11","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","volume":"56","author":"P Malfertheiner","year":"2007","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56:772\u201381.","journal-title":"Gut"},{"key":"1920_CR12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","volume":"61","author":"P Malfertheiner","year":"2012","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain C, et al. Management of Helicobacter pylori infection\u2014the Maastricht IV \/Florence Consensus Report. Gut. 2012;61:646\u201364.","journal-title":"Gut"},{"issue":"2","key":"1920_CR13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11695-012-0747-4","volume":"23","author":"RM Cerqueira","year":"2013","unstructured":"Cerqueira RM, Correia MR, Fernandes CD, et al. Cumulative Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery. Obes Surg. 2013;23(2):145\u20138.","journal-title":"Obes Surg"},{"key":"1920_CR14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","volume":"59","author":"DY Graham","year":"2010","unstructured":"Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010;59:1143\u201353.","journal-title":"Gut"},{"issue":"Pt 7","key":"1920_CR15","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1099\/jmm.0.009993-0","volume":"58","author":"L Boyanova","year":"2009","unstructured":"Boyanova L. Prevalence of multi-drug resistant Helicobacter pylori in Bulgaria. J Med Microbiol. 2009;58(Pt 7):930\u20135.","journal-title":"J Med Microbiol"},{"key":"1920_CR16","doi-asserted-by":"crossref","first-page":"e 442","DOI":"10.1371\/journal.pmed.0030442","volume":"3","author":"CD Mathers","year":"2006","unstructured":"Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e 442.","journal-title":"PLoS Med"},{"key":"1920_CR17","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/gut.2003.022111","volume":"53","author":"F M\u00e9graud","year":"2004","unstructured":"M\u00e9graud F. H pylori antibiotic resistance: prevalence, importance and advances in testing. Gut. 2004;53:1374\u201384.","journal-title":"Gut"},{"key":"1920_CR18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cgh.2009.09.030","volume":"8","author":"DC Wu","year":"2010","unstructured":"Wu DC, Hsu PI, Wu JY, et al. Sequential and concomitant therapy with 4 drugs are equally effective for eradication of H pylori infection. Clin Gastroenterol Hepatol. 2010;8:36\u201341.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"1920_CR19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1523-5378.2012.00947.x","volume":"17","author":"J Molina Infante","year":"2012","unstructured":"Molina Infante J, Pazos Pacheco C, Vinagre Rodriguez G, et al. Non bismuth quadruple concomitant therapy versus standard triple therapy for clarithromycin susceptible H pylori and versus quadruple sequential therapy for clarithromycin resistant H pylori. Helicobacter. 2012;17(4):269\u201376.","journal-title":"Helicobacter"},{"key":"1920_CR20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1523-5378.2009.00671.x","volume":"14","author":"AS Essa","year":"2009","unstructured":"Essa AS, Kramer JR, Graham DY, et al. Meta analysis: four drug, three antibiotic, non bismuth containing \u201cconcomitant therapy\u201d versus triple therapy for Helicobacter pylori. Helicobacter. 2009;14:109\u201318.","journal-title":"Helicobacter"},{"key":"1920_CR21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/CEG.S25419","volume":"5","author":"P Gisbert","year":"2012","unstructured":"Gisbert P, Calvet X. Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori. Clin Exp Gastroenterol. 2012;5:23\u201334.","journal-title":"Clin Exp Gastroenterol"},{"key":"1920_CR22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(11)60825-8","volume":"378","author":"ER Greenberg","year":"2011","unstructured":"Greenberg ER, Anderson GL, Morgan DR, et al. 14 days triple, 5 days concomitant, and 10 days sequential therapies for Helicobacter pylori infection in seven Latin America sites: a randomised trial. Lancet. 2011;378:507\u201314.","journal-title":"Lancet"},{"key":"1920_CR23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1523-5378.2011.00823.x","volume":"16","author":"AB Toros","year":"2011","unstructured":"Toros AB, Ince AT, Kesis B, et al. A new modified concomitant therapy for Helicobacter pylori eradication in Turkey. Helicobater. 2011;16:225\u20138.","journal-title":"Helicobater"},{"key":"1920_CR24","doi-asserted-by":"crossref","first-page":"18013","DOI":"10.3748\/wjg.v20.i47.18013","volume":"20","author":"R Zhu","year":"2014","unstructured":"Zhu R, Chen K, Zheng YY, et al. Meta-analysis of the efficacy of probiotics in Helicobacter pylori eradication therapy. W J Gastroenterol. 2014;20:18013\u201321.","journal-title":"W J Gastroenterol"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-015-1920-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11695-015-1920-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-015-1920-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T15:03:48Z","timestamp":1567263828000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11695-015-1920-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,14]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["1920"],"URL":"https:\/\/doi.org\/10.1007\/s11695-015-1920-3","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,14]]}}}